Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 13,723,681 $ 17,002,715
Investments 7,182,325 42,194,296
Restricted cash 192,475 192,475
Prepaid expenses and other current assets 2,447,549 791,616
Total current assets 23,546,030 60,181,102
Restricted cash 477,425 477,425
Property and equipment, net 973,214 1,613,815
Operating lease right-of-use assets 3,062,920 3,884,252
Other assets 212,804 155,346
Total assets 28,272,393 66,311,940
Current liabilities:    
Notes payable 300,664 353,323
Accounts payable 3,178,516 2,173,963
Accrued expenses 11,030,506 5,999,252
Derivative liability 39,450 36,868
Operating lease liabilities, current 1,436,723 1,280,863
Current portion of long-term debt 15,908,214 2,795,669
Total current liabilities 31,894,073 12,639,938
Long-term debt, net of debt discount 0 15,984,426
Other long-term liabilities 44,411 22,205
Operating lease liabilities, noncurrent 3,238,631 4,675,354
Total liabilities 35,177,115 33,321,923
Stockholders' equity    
Preferred stock, $0.0001 par value; 10,000,000 shares authorized, no shares issued and outstanding at December 31, 2023 and December 31, 2022. See Note 12 0 0
Common stock, $0.0001 par value; 300,000,000 shares authorized, 4,423,683 and 4,171,297 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively 442 417
Additional paid-in capital 429,780,375 425,196,359
Accumulated deficit (436,683,983) (392,080,667)
Accumulated other comprehensive loss (1,556) (126,092)
Total stockholders’ equity (6,904,722) 32,990,017
Total liabilities and stockholders’ equity $ 28,272,393 $ 66,311,940